@failedLyndonLaRouchite @DeanBaker13 @merz @jgordon all I’ve endorsed was having the state pay to overcome regulatory burdens for already developed drugs that would be competitive with domestic monopolists. i’m sympathetic to @DeanBaker13’s broad project of figuring out how to reorganize pharma so we keep the competences but trim the rents and the (profound) incentives to corruption and predation under the current model. but i’m not going to invent a new model in a toot.